NCT03326856View on ClinicalTrials.gov

ET-01 in Subjects With Lateral Canthal Lines

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

June 11, 2018

Study Completion Date

November 14, 2018

Conditions
Lateral Canthal LinesCrow's Feet
Interventions
BIOLOGICAL

botulinum toxin, Type A

topical liniment

BIOLOGICAL

Vehicle

Vehicle Formulation

Trial Locations (1)

27519

Cary Skin Care, Cary

Sponsors
All Listed Sponsors
lead

Eirion Therapeutics Inc.

INDUSTRY